A novel Anti-ROS osteoblast-specific delivery system for ankylosing spondylitis treatment via suppression of both inflammation and pathological new bone formation

Ankylosing spondylitis (AS) is a common rheumatic disorder distinguished by chronic inflammation and heterotopic ossification at local entheses sites. Currently available medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs) and TNF inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Guan, Peng, Xiaoshuai, Zhang, Yunhui, Wang, Peng, Xie, Zhongyu, Li, Jinteng, Liu, Wenjie, Ye, Guiwen, Lin, Yucong, Li, Guojian, Liu, Huatao, Zeng, Chenying, Li, Lihua, Wu, Yanfeng, Shen, Huiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214592/
https://www.ncbi.nlm.nih.gov/pubmed/37231465
http://dx.doi.org/10.1186/s12951-023-01906-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214592/
https://www.ncbi.nlm.nih.gov/pubmed/37231465
http://dx.doi.org/10.1186/s12951-023-01906-2

Ejemplares similares